“No Donor”? Consider a Haploidentical Transplant

Blood Reviews - United States
doi 10.1016/j.blre.2014.09.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Selecting the Best Haploidentical Donor

Seminars in Hematology
Hematology
2016English

Developing a Haploidentical Transplant Program: An Indian Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, KIR Genotyping, and Other Clinical Variables

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Acute Renal Transplant Dysfunction in a Living Donor Kidney Transplant Recipient

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2019English

Haploidentical BMT and Post Transplant Cyclophosphamide: First Peruvian Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Delayed Immune Reconstitution and Increased Viral Infections Following Haploidentical BMT With Post-Transplant Cyclophosphamide for Sickle Cell Disease: Results of a Haploidentical Transplant Consortium for Hemoglobinopathies (ICHH)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

How to Select Donor, Stem Cell Source, and Conditioning Regimen for Haploidentical Transplants With Post-Transplant Cyclophosphamide for Lymphoma: A Report of the Ebmt LWP

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Post-Transplant Cyclophosphamide (PTCy)-Based Haploidentical (Haplo) Donor vs. Calcineurin-Inhibitor (CNI)-Based Matched Related Donor (MRD) Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy